British & American Investment Trust : Reporting Dpcument
June 30, 2023 at 06:20 am EDT
Share
BRITISH & AMERICAN INVESTMENT TRUST PLC
30 JUNE 2023
Annual General Meeting on 29 JUNE 2023
British & American Investment Trust PLC announces that, at the Annual General Meeting held on Tuesday, all nine resolutions proposed were duly passed.
The full text of the resolutions can be found in the Notice of Annual General Meeting set out on page 75 of the Report & Accounts for the year ended 31 December 2022, copies of which have been submitted to the National Storage Mechanism, and will be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.
The results of the polls are as follows:
Resolution
For
Against
Votes
withheld
1. Receiving the report and accounts
17,089,975
14,285
nil
2. Re-election of Mr DG Seligman as a director
17,088,975
15,285
nil
3. Re-election of Mr A Tamlyn as a director
17,088,975
15,285
nil
4. Re-election of Mr JC Woolf as a director
17,088,975
15,285
nil
5. Re-election of Mrs J Le Blan as a director
17,088,975
15,285
nil
6. Approval of the directors' remuneration report (excluding policy)
17,056,464
47,796
nil
7. Approval of the directors' remuneration policy
17,056,464
47,796
nil
8. Appointment of Hazlewoods LLP as the company's auditors
17,089,975
14,285
nil
9. Authority to determine the remuneration of the auditors
17,089,975
14,285
nil
On 29 June 2023 there were 25,000,000 relevant shares in issue. Shareholders are entitled to one vote per share. Votes withheld are not votes and, therefore, have not been counted in the calculation of the proportion of votes for and against a resolution.
British and American Investment Trust plc published this content on 30 June 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 30 June 2023 10:19:21 UTC.
British & American Investment Trust PLC is a self-managed investment trust company. The Company invests in investment trusts and other United Kingdom and United States-quoted companies. The Companyâs investment portfolio includes Lineage Cell Therapeutics (USA), Dunedin Income Growth, Geron Corporation (USA), Aberdeen Diversified Income & Growth, Relief Therapeutics (Switzerland), AgeX (USA), Audioboom Group, ADVFN, Braemar Shipping Services and Electra Private Equity. The Company's invests sectors include biotechnology, investment trust, biomedical, healthcare, media, semiconductors and telecommunications.